The evaluation of tissue kallikrein in Helicobacter pylori-associated gastric ulcer disease.
Helicobacter pylori (Hp) associated ulcer disease is a common form of gastric disorder involving mucosal damage and invasion of the mucosa by polymorphic inflammatory cells with concomitant changes in the epithelial cell structure. The bacteria are thought to adhere by specific junction zones to the epithelial cell surface resulting in the degeneration of the mucosal layer. Our study was undertaken to examine the relative status of tissue kallikrein (TK) in antral and fundic biopsies, endoscopically obtained from 10 patients suspected of having gastric disorders. For histological evidence of inflammation the tissue was stained with hematoxylin and eosin and classified as mild, active, chronic and chronic active gastritis. Hp infection was determined by Giemsa staining. For localisation of TK, slide-mounted tissue sections were subjected to PAP and immunofluorescent staining using a goat anti-human TK IgG antibody. The results revealed that in the antral control tissue, removed during partial antractomy, TK was immunovisualised along the luminal border of the deep pyloric glands. The surface epithelia and superficial glands showed no labelling. The fundic control tissue revealed an absence of TK in the superficial and surface epithelial glands, but was positive in the parietal cells. The fundic biopsy specimens showed similar immunoreactivity in these areas. By contrast, in the inflammed pyloric mucosa, there was a shift of TK localisation to the basal part of the glandular cells and there was also expression of TK in the superficial glands that showed histological evidence of regeneration. In the fundic biopsies there was no change observed in the sites of TK localisation (similar to control tissue). It was observed, that even though 8 of the 10 subjects exhibited Hp infection, the inflamed mucosa showed no discernable difference in the staining patterns between the infected and non-infected tissue sections. Our findings suggest an important role for a B1/B2 kinin antagonist in patients with gastritis.
Naidoo
S
S
Department of Experimental and Clinical Pharmacology, University of Natal Medical School, Durban, South Africa. naidoot@und.med.ac.za
Ramsaroop
R
R
Bhoola
R
R
Bhoola
K D
KD
D000293:Adolescent; D000328:Adult; D000368:Aged; D000918:Antibody Specificity; D001706:Biopsy; D004801:Eosine Yellowish-(YS) / Q000737:chemistry; D005260:Female; D005748:Gastric Fundus; D005753:Gastric Mucosa / Q000737:chemistry / Q000378:metabolism* / Q000473:pathology; D005773:Gastroscopy; D016481:Helicobacter Infections / Q000378:metabolism* / Q000503:physiopathology; D006416:Hematoxylin / Q000737:chemistry; D006801:Humans; D007124:Immunoenzyme Techniques; D007074:Immunoglobulin G / Q000276:immunology; D016234:Kallikrein-Kinin System / Q000502:physiology; D007610:Kallikreins / Q000032:analysis / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010437:Peptic Ulcer / Q000175:diagnosis / Q000378:metabolism* / Q000503:physiopathology; D011706:Pyloric Antrum; D013194:Staining and Labeling; D020840:Tissue Kallikreins
D007074:Immunoglobulin G; D007610:Kallikreins; D020840:Tissue Kallikreins; D004801:Eosine Yellowish-(YS); D006416:Hematoxylin